» Articles » PMID: 25171812

Bone Marrow-Derived Stem Cells and Strategies for Treatment of Nervous System Disorders: Many Protocols, and Many Results

Overview
Journal Neuroscientist
Publisher Sage Publications
Specialty Neurology
Date 2014 Aug 31
PMID 25171812
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Bone marrow stem cells are the best known stem cell type and have been employed for more than 50 years, especially in pathologies of the hematopoietic and immune systems. However, their therapeutic potential is much broader, and they can also be employed to palliate neural diseases. Apart from their plastic properties, these cells lack the legal or ethical constraints of other stem cell populations, that is, embryonic stem cells. Current research addressing the integration of bone marrow-derived cells into the neural circuits of the central nervous system, their features, and applications is a hotspot in neurobiology. Nevertheless, as in other leading research lines the efficacy and possibilities of their application depend on technical procedures, which are still far from being standardized. Accordingly, for efficient research this large range of variants should be taken into account as they could lead to unexpected results. Rather than focusing on clinical aspects, this review offers a compendium of the methodologies aimed at providing a guide for researchers who are working in the field of bone marrow transplantation in the central nervous system. It seeks to be useful for both introductory and trouble-shooting purposes, and in particular for dealing with the large array of bone marrow transplantation protocols available.

Citing Articles

Intracerebellar injection of monocytic immature myeloid cells prevents the adverse effects caused by stereotactic surgery in a model of cerebellar neurodegeneration.

Del Pilar C, Garrido-Matilla L, Del Pozo-Filiu L, Lebron-Galan R, Arias R, Clemente D J Neuroinflammation. 2024; 21(1):49.

PMID: 38355633 PMC: 10867997. DOI: 10.1186/s12974-023-03000-8.


Exosomes derived from mesenchymal stem cells inhibit neointimal hyperplasia by activating the Erk1/2 signalling pathway in rats.

Liu Z, Wu C, Zou X, Shen W, Yang J, Zhang X Stem Cell Res Ther. 2020; 11(1):220.

PMID: 32513275 PMC: 7278178. DOI: 10.1186/s13287-020-01676-w.


Aberrant cerebellar Purkinje cell function repaired in vivo by fusion with infiltrating bone marrow-derived cells.

Kemp K, Dey R, Verhagen J, Scolding N, Usowicz M, Wilkins A Acta Neuropathol. 2018; 135(6):907-921.

PMID: 29541917 PMC: 5954067. DOI: 10.1007/s00401-018-1833-z.


Olfactory bulb plasticity ensures proper olfaction after severe impairment in postnatal neurogenesis.

Diaz D, Munoz-Castaneda R, Avila-Zarza C, Carretero J, Alonso J, Weruaga E Sci Rep. 2017; 7(1):5654.

PMID: 28720887 PMC: 5516035. DOI: 10.1038/s41598-017-05970-1.


Low-dose irradiation prior to bone marrow transplantation results in ATM activation and increased lethality in Atm-deficient mice.

Pietzner J, Merscher B, Baer P, Duecker R, Eickmeier O, Fussbroich D Bone Marrow Transplant. 2016; 51(4):560-7.

PMID: 26752140 DOI: 10.1038/bmt.2015.334.